The aim of this pilot study was to compare renal transplant biopsies carried out by ward-based nephrology trainees and departmental based radiologists, primarily reviewing major complications and glomerular yield. There was only one patient who developed a single episode of major complication out of the 145 procedures recorded. We concluded there is no significant difference in complication rate and glomerular yield for renal allograft biopsies between nephrology trainees and radiologists, regardless of location.
Introduction
Renal biopsy is a well established investigation, providing important information regarding diagnosis and prognosis of many medical conditions. Like liver biopsy, this procedure can be performed by physicians, surgeons and radiologists as the skill can be acquired with time and practice. 1 Dysfunctional renal alleografts after renal transplantation often require urgent histological assessment. As radiological resources are not unlimited, some transplant units have therefore elected to perform ward-based percutaneous biopsies by clinicians in order to obtain prompt diagnosis. To date, there has been no rigorous trial to compare the safety and adequacy of renal transplant biopsies between physicians on the ward and radiologists in the radiology department.
This study was carried out primarily to review the major complication rate needing intervention and glomerular yield between bedside renal transplant biopsies performed by nephrology trainees and departmental biopsies performed by radiologists. Minor complications such as self-limiting small perirenal hemorrhage, pain and hematuria are not discussed in this article. 
Method

Results
Four cases were excluded due to incomplete data. There were 93 and 52 biopsies carried out by nephrology trainees and radiologists respectively. The overall major complication rate was surprisingly low at 0.7%. There was only one major complication out of all the cases reviewed. This was an episode of significant hemorrhage noted in the nephrology group. The patient developed perirenal hemorrhage and hydronephrosis due to ureteric blood clots, requiring nephrostomy and a blood transfusion before making an uneventful recovery. Despite this event, there was no statistical significance (P value = 1.0) of complication rate between the two groups. The risk difference was 0.01 (95% confidence interval [CI] -0.02 to 0.04). Although adequacy of tissue samples in both groups is similar (44.1% versus 44.2%), clinicians appeared to have a higher likelihood of obtaining insufficient renal tissues (5.38% versus 1.92%). However, this again did not achieve any statistical significance (P value = 0.32). There were no deaths or graft losses. Other details are summarized in Table 1 . Table 2 shows that there was no increased risk of hemorrhage in patients with relatively high international normalized ratio (INR) (1.4-1.6) at the time of biopsies (P value 0.65).
Discussion
There has been a study in recent years involving 37 patients reporting the complication rate between radiologists and nephrologists in native kidney biopsies. 3 To our knowledge, this is the first study to analyze the safety and glomerular yield of renal transplant biopsies between nephrology trainees and radiologists. The low incidence of complication in comparison to other studies is possibly due to the use of 18G biopsy needles. 4 Furthermore, renal allograft biopsy complication rate is generally lower than that of native biopsies.
This research has shown that there is no significant difference in major complication rate of renal allograft biopsies, whether these are performed by nephrology trainees on the ward or by radiologists in radiology departments. Furthermore, glomerular yield measurements are also comparable between the two groups thereby ensuring quality of the biopsies is consistent. The obvious limitations to this study include it being a single center study, and a retrospective review rather than a randomized controlled trial. Other confounders that should be taken into account include different rooms, operators and ultrasound machines used for each procedure.
In conclusion, we have not found any difference in risk between bedside and departmental biopsies. Hospitals should consider investing in portable ultrasound machines to facilitate physicians performing bedside biopsies. This would enable the prompt diagnosis and treatment for transplant recipients by increasing the number of clinicians who are able to perform this procedure. Apart from enabling clinicians to establish a prompt diagnosis, ward-based biopsy could also be time and cost-effective. It has been estimated that the cost of a hospital stay per patient per day in the United Kingdom ranges between £200 to £1,000 (depending on the type of ward and care required). It is not uncommon for patients to be deferred more than 24 hours in centers that lack expertise or dedicated biopsy sessions. For every 10 in-patients that are delayed by a day in undergoing the procedure could potentially incur an extra £2,000 to £10,000 pounds to the center. In addition to this, time efficiency (time saved from decision to the actual biopsy procedure) could be dramatically improved. Therefore, it seems logical to have the additional option of non-radiologists performing Ward-based renal transplant biopsies the procedure in the interests of time, cost and patient care. Similar studies on a larger scale involving multiple centers will be invaluable to further evaluate the outcome of native and transplant kidney biopsies in order to ensure patients are given timely optimal care and at the same time, not subjected to unnecessary risks.
